Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Continued Early Intervention for Recent-onset Schizophrenia [Phase 3]
A Phase 3 trial evaluating continued early intervention for recent-onset schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A completed pilot cohort study assessing how common comorbid mental illness and substance use disorders are, including schizophrenia and rel…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia [Phase 3]
Phase 3 study update evaluating brexpiprazole as maintenance therapy for adults with schizophrenia, focusing on efficacy, safety, and tolera…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) [Phase 2]
Phase 2 trial update for transcranial magnetic stimulation for negative symptoms in schizophrenia and schizoaffective disorder. The study wa…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia [Phase 2]
A Phase 2 trial assessed the effects of transdermal nicotine on smoking, craving, and withdrawal in people with schizophrenia; the study has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 [Phase 2]
This Phase 2 trial evaluated the effectiveness of bupropion for nicotine dependence in individuals with schizophrenia and has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 [Phase 2]
A Phase 2 clinical trial evaluating flupenthixol in individuals with schizophrenia and cocaine use has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
This completed clinical trial evaluated nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder. The trial w…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia [Phase 2]
This clinical trial update summarizes a Phase 2 study evaluating whether bupropion affects smoking behavior in individuals with schizophreni…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1 [Phase 4]
Phase 4 trial of a nicotine patch for nicotine dependence in individuals with schizophrenia or schizoaffective disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke [Phase 4]
Phase 4 trial update examining the safety and effectiveness of sustained-release bupropion in people with schizophrenia who smoke; the study…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Cognitive Enhancement Therapy for Early-Stage Schizophrenia [Phase 3]
Phase 3 clinical trial of Cognitive Enhancement Therapy for early-stage schizophrenia has completed. The sponsor listed is Beth Israel Deaco…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Pregablin for Anxiety-comorbidity in Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluating pregabalin for anxiety comorbidity in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Contingency Management of Alcohol Abuse in the Severely Mentally ILL [NA]
This clinical trial update reports the completed results of a contingency management intervention for alcohol use disorder in individuals wi…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects [Phase 1]
Phase I safety and pharmacokinetics study of oral Anvylic-3288 in healthy subjects; the trial has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1 and Phase 2 studies evaluating transcranial direct current stimulation (tDCS) f…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Electroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study [NA]
A randomized, double-blind, sham-controlled trial evaluating electroconvulsive therapy for treatment-refractory schizophrenia was terminated…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications [NA]
A completed clinical trial evaluating MedActive, a smartphone intervention intended to improve adherence to antipsychotic medications in sch…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: F17464 in Acute Schizophrenia Trial [Phase 2]
A Phase 2 clinical trial evaluating F17464 for acute schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Pharmacotherapy for Schizophrenic Drug Users - 6 [Phase 2]
Phase 2 trial update on pharmacotherapy for individuals with schizophrenia who use drugs; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) [Phase 2]
Phase 2 trial investigating a glycine uptake inhibitor as adjuvant treatment for negative symptoms in schizophrenia has completed with resul…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628) [Phase 2]
Phase 2 clinical trial of preladenant for antipsychotic-induced movement disorders in schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: To Rescue Cognition With Valaciclovir [Phase 2]
Phase 2 clinical trial update on valaciclovir for cognitive rescue in schizophrenia/psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Yoga as Cognitive Remediation in Schizophrenia [NA]
A completed clinical trial evaluating yoga as cognitive remediation in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Upside Down, Give me the Handle [NA]
A clinical trial in schizophrenia sponsored by Centre Hospitalier Universitaire de Saint Étienne has completed.